ICD-10 Coding for Stage 4 Lung Cancer(C34.0, C34.11, C34.11B)
Comprehensive guide to ICD-10 coding for stage 4 lung cancer, including primary and metastatic site codes, documentation requirements, and common pitfalls.
Complete code families applicable to Stage 4 Lung Cancer
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| C34.11 | Malignant neoplasm of upper lobe, right bronchus or lung | Use when primary tumor is located in the right upper lobe. |
|
| C79.31 | Secondary malignant neoplasm of brain | Use when brain metastasis is confirmed in a patient with primary lung cancer. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutStage 4 Lung Cancer
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Stage 4 Lung Cancer.
Omitting metastatic site codes
Impact
Clinical: Incomplete clinical picture., Regulatory: Non-compliance with coding standards., Financial: Potential for denied claims.
Mitigation
Review imaging and pathology for all metastatic sites., Ensure all sites are coded.
Using unspecified codes like C34.90
Impact
Reimbursement: May lead to reduced reimbursement due to lack of specificity., Compliance: Non-compliance with coding guidelines., Data Quality: Poor data quality affecting clinical decision-making.
Mitigation
Always specify laterality and lobe for accurate coding.
Use of unspecified codes
Impact
High risk of audits due to lack of specificity.
Mitigation
Ensure all documentation specifies laterality and metastatic sites.